Seeking Alpha30/09/2026 12:03:43

Zenas BioPharma, Inc. (ZBIO) Discusses Obexelimab Prelaunch Strategy and Commercial Opportunity in IgG4-Related Disease Transcript

Zenas BioPharma, Inc. (ZBIO) Discusses Obexelimab Prelaunch Strategy and Commercial Opportunity in IgG4-Related Disease Transcript

By SA Transcripts
1 hour ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Tesla enters $30B credit agreements to fund expansion

21 min ago

Japan's industrial output drops 1.7% M/M in August; retail sales rise 2.7% Y/Y

25 min ago

Australia's August inflation rises to 4.0%, slightly below expectations

32 min ago

MongoDB, Inc. (MDB) Analyst/Investor Day - Slideshow

33 min ago